CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety.

Introduction: Dengue virus (DENV) is a serious global health problem. CYD-TDC (Dengvaxia) was the first vaccine to gain regulatory approval to try and address this problem.

Aim: Summarize all available evidence on the immunogenicity, efficacy and safety of the CYD-TDV dengue vaccine.